Biotechs grabbed $1.83B in VC cash in Q3. Still fast but a little less furious
Biotech VCs in the US continued to steam along in the third quarter, racking up $1.8 billion in new investments. That marks a slight drop …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
